Search

Search Constraints

You searched for: Author/Creator Kastelein, John J P

Search Results

1. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 9983 (30th May 2015)

2. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Issue 7 (July 2015)

3. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Issue 7 (July 2015)

4. Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. Issue 9992 (1st August 2015)

6. Combination lipid-lowering therapy as first-line strategy in very high-risk patients. (12th October 2021)

7. Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition. Issue 2 (28th October 2022)

8. Effect of rimonabant on carotid intima–media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial. Issue 14 (24th May 2011)

10. Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease. Issue 20 (5th April 2018)